NASDAQ:CHNA Loncar China Biopharma ETF (CHNA) Price, Holdings, & News → my top trade on these 9 tickers (From DTI) (Ad) Free CHNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$13.53▼$13.5350-Day Range$13.53▼$14.7752-Week Range$13.35▼$22.89Volume100 shsAverage Volume538 shsMarket Capitalization$3.79 millionAssets Under Management$3.74 millionDividend Yield0.44%Net Expense Ratio0.79% Stock AnalysisStock AnalysisDividendHeadlinesHoldingsRatingsSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsSocial Media Get Loncar China Biopharma ETF alerts: Email Address About Loncar China Biopharma ETF (NASDAQ:CHNA)The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.Read More Ad Behind the MarketsThe Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.Get the full story here >>> CHNA ETF News HeadlinesFebruary 6, 2024 | investing.comMiraeAsset TIGER China Biotech Solactive ETF (371470)January 20, 2024 | investing.comChina Southern CSI Cmunctn Srvcs ETF (159511)March 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.December 30, 2023 | nasdaq.comThis ETF Has Depth Needed for China ReboundDecember 21, 2023 | money.usnews.comChina Bans Export of Rare Earths Processing TechnologiesDecember 19, 2023 | msn.comChina Sinochem Buys Rare Venezuelan Oil Cargo After U.S. Suspends Sanctions - SourcesDecember 16, 2023 | investing.comChina Universal Nasdaq 100 ETF (QDII) (159660)December 13, 2023 | investing.comAmundi MSCI China A II ETF (C024)March 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… December 12, 2023 | investing.com2823 ETF Stock Price HistorySee More Headlines Receive CHNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerExchange Traded Concepts Fund NameLoncar China Biopharma ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHNA Inception Date8/14/2018 Fund ManagerDenise M. Krisko, Habib Moudachirou WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkLoncar China BioPharma Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings89 Fund Statistics Assets Under Management$3.74 million Average Daily Volume$1,200.80 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares280,000Beta0.67 Creation Unit50,000 Creation Fee$750.00 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here Loncar China Biopharma ETF ExpensesTypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.57%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.32%0.58%Total Expense0.79%0.72%0.70%0.57%0.70%Fee Waiver0.00%-0.53%-0.54%-0.20%-0.56%Net Expense0.79%0.61%0.60%0.54%0.58% Loncar China Biopharma ETF (CHNA) HoldingsTop 10 CHNA HoldingsAIM Vaccine Co Ltd Class HHolding Weight: 4.27%Legend Biotech(NASDAQ:LEGN)Holding Weight: 3.11%Sinopharm Group Co LtdHolding Weight: 2.54%Shanghai Fosun Pharmaceutical (Group) Co Ltd Class HHolding Weight: 2.36%Wuxi AppTec Co LtdHolding Weight: 2.24%BeiGene(NASDAQ:BGNE)Holding Weight: 2.17%Hansoh Pharmaceutical Group Co LtdHolding Weight: 2.12%Sino Biopharmaceutical LtdHolding Weight: 2.12%Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class HHolding Weight: 2.05%Shanghai Pharmaceuticals Holding Co Ltd Class HHolding Weight: 2.04%Full Holdings Details Similar ETFsProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISJPMorgan Healthcare Leaders ETFNASDAQ:JDOCHorizon Kinetics Medical ETFNASDAQ:MEDXFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQ CHNA ETF - Frequently Asked Questions How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF? Loncar China Biopharma ETF declared an annual dividend on Friday, October 13th. Investors of record on Tuesday, October 17th will be given a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date of this dividend is Monday, October 16th. Read our dividend analysis for CHNA. What does CHNA invest in? Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management. What stocks does Loncar China Biopharma ETF hold? CHNA invests in 89 holdings. Some of the stocks in their portfolio include Legend Biotech (LEGN), BeiGene (BGNE), HUTCHMED (HCM), Zai Lab (ZLAB) and LianBio (LIAN). What is the management fee for Loncar China Biopharma ETF? Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%. What other stocks do shareholders of Loncar China Biopharma ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI). This page (NASDAQ:CHNA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loncar China Biopharma ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.